In the News

Advances in the Medical Treatment of Thyroid Eye Disease: Current and Emerging Therapies

APRIL 18, 2024

Thyroid eye disease (TED) is a complex, autoimmune condition that can be sight-threatening and disfiguring. This disease poses significant diagnostic and therapeutic challenges, with limited therapies available. Recent advances in our understanding of the pathophysiology of TED have shifted the focus of treatment towards early intervention with targeted biological therapies. Read this paper in touchREVIEWS in Ophthalmology.

Thyroid Eye Disease 360˚ Guidance: Pathogenesis, Differential Diagnosis, and Medical Trends

MARCH 19, 2024

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc., and is cerftified for 1.50 CME credit hour. The activity will be available for the duration of 1 year expiring on February 28, 2025.

Thyroid Eye Disease 360° Guidance: Surgical Procedures, Research Trends, and Case Challenges

MARCH 19, 2024

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc., and is cerftified for 1.50 CME credit hour. The activity will be available for the duration of 1 year expiring on February 28, 2025.

Celebrating Female Authors in Ophthalmology

JUNE 29, 2022

Dagny Zhu, MD, and Laura M. Periman, MD, talk with Andrea L. Kossler, MD, Cherie A. Fathy, MD, MPH, and Bonnie A. Henderson, MD, about the incredible accomplishments of female authors in ophthalmology journals, ways to encourage growth and limit disparities and more.

Conversations in Thyroid Eye Disease

FEB 15, 2022

Conversations in Thyroid Eye Disease provides an in-depth look at novel treatments and new studies affecting patients with TED and Graves'  Disease.

Insulin-like Growth Factor 1-Receptor Inhibitors in Thyroid Eye Disease: Developing a Consensus to Address and Manage Hearing-Related Impairment

JAN 18, 2022

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.

AAO TED Roundtable Discussion PART 2

DEC 22, 2021

View full video here

AAO TED Roundtable Discussion PART 1

DEC 22, 2021

View full video here

The Impact on Ocular Surface Disease of Teprotumumab for TED

NOV 23, 2021

We recently spoke with Andrea Lora Kossler, MD, FACS, from the Byers Eye Institute at Stanford University about results from the study “Effect of Teprotumumab on Ocular Surface Disease in Active Thyroid Eye Disease,” which she and colleagues presented at the American Society or Ophthalmic Plastic & Reconstructive Surgery Annual Fall Scientific Symposium.

Mitigating Thyroid Eye Disease Through Prompt Diagnosis and Treatment

SEPT 27, 2021

Thyroid eye disease (TED) is often misdiagnosed due to the heterogeneity of clinical presentation, resulting in postponed treatment initiation and reduced effectiveness of therapy.

New Frontiers in Thyroid Eye Disease Management

JAN 27, 2021

In this session from AAO 2020 Virtual, Drs. Andrea Kossler and Sara Wester share their experience in using teprotumumab for thyroid eye disease (TED). Patients with TED can show varied response to the drug, which highlights the heterogeneity of the disease.

Techniques in Corneal Neurotization

SEPT 1, 2020

This comprehensive text on corneal neurotization provides an in-depth understanding of various available surgical techniques, as well as the relevant anatomy, physiology, and pathogenesis governing the principles of this innovative surgery.

6 Commonly Neglected Places for Sunscreen and How Doctors Recommend Protecting Them

JULY 7, 2020

As we continue to be inundated with Instagram memes about the importance of wearing sunscreen and countless campaigns warning of skin cancer's horrors, it's hard to believe that there was ever a time when it was normal to lie in the sun, not a care in the world, lathering yourself in tanning oil.

You Missed A Spot! Patchy Sunscreen Application Leaves Skin Vulnerable To Cancer

APRIL 3, 2019

You may not be thin-skinned, but your eyelids certainly are. The fragile tissue is the thinnest on the body, less than 1 millimeter thick.

The gift of sight

JULY 1, 2019

Almost four years ago, Peggy Kixmoeller was diagnosed with thyroid eye disease (TED). This is an autoimmune disorder where the body mistakenly attacks healthy cells, specifically the thyroid gland and the tissues around the eye.

A delicate surgery saves a teenager’s eye

SEPT 7, 2017

When Nhu Nguyen came to Stanford to seek help for her left eye, she felt like she was living in a nightmare. Nguyen, then 16, had undergone surgery at another California hospital to remove a small, benign dermoid eye tumor she'd been born with.

Andrea Kossler, MD: Why I Went Into Medicine

MAY 23, 2016

The father of Andrea Kossler, MD, is a surgeon and her sister an ophthalmologist, so she was torn between those two specialties. After medical aid trips to Bolivia and Cambodia, she figured out that oculoplastic surgery would be just right. It was the perfect fit for her.

Navy Pilot's Medical Mystery Solved by Three Stanford Experts

JULY 8, 2014

Stanford's laryngology division chief, Ed Damrose, has nearly 20 years of practice under his belt, but what he observed in U.S. Navy Cmdr. Robert Buchanan stumped him. "I had never encountered anything quite like it before," Damrose said.